Game-Changing EU-Level HTA Regs Must Allow For Lessons To Be Learned

EU joint clinicals assessments introduced under the HTA Regulation have now gone live for cancer medicines and advanced therapies.

Paper
Joint clinical assessments mean big change for Europe's pricing and reimbursement landscape (Shutterstock)

More from Europe

More from Market Access